Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Mindray Medical Q4 Profit Rises - Quick Facts

RELATED NEWS
Trade MR now with 

Mindray Medical International Limited (MR: Quote) announced that its fourth quarter 2011 net income attributable to the Company was $46.8 million up from $41.0 million in the fourth quarter of 2010. Earnings per share were $0.40, up from $0.35 in the fourth quarter of 2010.

Non-GAAP net income increased 14.2% to $51.8 million from $45.4 million in the fourth quarter of 2010. Non-GAAP earnings per share were $0.44, compared to $0.38 in the fourth quarter of 2010.

Net revenues were $264.1 million for the fourth quarter of 2011, a 25.2% increase from $211.0 million in the fourth quarter of 2010.

Analysts polled by Thomson Reuters expected the company to report earnings of $0.41 per share on revenues of $249.17 million for the quarter. Analysts' estimates typically exclude special items.

Mindray's board has declared a cash dividend on its ordinary shares of $0.40 per share, based on the company's net income for the full year 2011. The cash dividend will be payable on or around April 10, 2012, to shareholders of record as of March 9, 2012.

The company expects its full year 2012 net revenues to grow at least 18% over its full year 2011 net revenues. The company also expects its full year 2012 non-GAAP net income to grow at least 13% over its non-GAAP net income for full year 2011. Analysts expect the company to report earnings of $1.69 per share on revenues of $1.03 billion for foscal 2012.

The company expects its capital expenditure for 2012 to be around $90 million.

Register
To receive FREE breaking news email alerts for Mindray Medical International Ltd. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
A ban on athletes using stamina-boosting gases - xenon and argon - came into effect on Monday. The World Anti-Doping Agency (WADA) said Hypoxia-Inducible Factor (HIF) activators Xenon and Argon have been added to the 2014 List of Prohibited Substances and Methods List following the required three-month notice period and UNESCO's communication to all States Parties. A recommendation to revise the British manufacturing growth eased further in August to its lowest level in 14 months as output and demand increased at slower rates, survey results from Markit Economics showed Monday. The Markit/CIPS Purchasing Managers' Index dropped to 52.5 from a revised 54.8 in July. Economists had expected the score to fall to 55.1 from July's original figure of 55.4. Consumers spent less in July than in the previous month, a surprise retreat that complicates the prevailing belief that the U.S. economic situation is improving. Along with the unexpected drop in spending, government figures released on Friday showed that incomes rose at a slower pace in July than in the previous month. Meanwhile, data on prices indicated that inflation pressures remain tame.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.